Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

Eli Lilly announced a $6 billion investment in a manufacturing campus in northern Alabama to boost production of its next-generation medicines for obesity and metabolic diseases. This project is part ...

In Huntsville, Alabama, pharma giant Eli Lilly and Company has revealed it plans to invest more than $6 billion to establish a new manufacturing facility. This is the third of four new U.S. sites ...

Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half of the company's revenue comes from just two weight loss drugs. Wall Street may be pricing in too ...

Morgan Stanley sees Eli Lilly winning new ground over Novo Nordisk as obesity and diabetes drugs reshape the company’s outlook and bump its future price target. GLP-1 therapies—those buzzy medicines ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...

Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...

Eli Lilly briefly reached a $1 trillion market cap, a first for any health-care company. LLY shares traded around $1,059 as demand for GLP-1 drugs surged. Mounjaro and Zepbound generated billions in ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 diabetes. A recent trial showed the drug enabled people with both conditions to ...

And now there are 10 trillion-dollar companies as Eli Lilly joined the thirteen-digit club Friday. After hitting that mark earlier in the day, the pharmaceutical company also closed with a market ...